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Abstract 40 
Introduction:  Obesity is a major risk factor for several musculoskeletal conditions 41 
that are characterized by an imbalance of tissue remodeling. Adult stem cells are 42 
closely associated with the remodeling and potential repair of several mesodermally 43 
derived tissues such as fat, bone, and cartilage. We hypothesized that obesity would 44 
alter the frequency, proliferation, multipotency, and immunophenotype of adult stem 45 
cells from a variety of tissues.  46 
Materials and Methods: Bone marrow-derived mesenchymal stem cells (MSCs), 47 
subcutaneous adipose-derived stem cells (sqASCs), and infrapatellar fat pad-derived 48 
stem cells (IFP cells) were isolated from lean and high-fat diet induced obese mice, 49 
and their cellular properties were examined. To test the hypothesis that changes in 50 
stem cell properties were due to the increased systemic levels of free fatty acids 51 
(FFAs), we further investigated the effects of FFAs on lean stem cells in vitro. 52 
Results:  Obese mice showed a trend toward increased prevalence of MSCs and 53 
sqASCs in the stromal tissues. While no significant differences in cell proliferation 54 
were observed in vitro, the differentiation potential of all types of stem cells was 55 
altered by obesity. MSCs from obese mice demonstrated decreased adipogenic, 56 
osteogenic, and chondrogenic potential. Obese sqASCs and IFP cells showed 57 
increased adipogenic and osteogenic differentiation, but decreased chondrogenic 58 
ability. Obese MSCs also showed decreased CD105 and increased PDGFRα 59 
expression, consistent with decreased chondrogenic potential. FFA treatment of lean 60 
stem cells significantly altered their multipotency but did not completely recapitulate 61 
the properties of obese stem cells.  62 
Conclusions: These findings support the hypothesis that obesity alters the properties 63 
of adult stem cells in a manner that depends on the cell source. These effects may be 64 
regulated in part by increased levels of FFAs, but may involve other obesity-65 
associated cytokines. These findings contribute to our understanding of mesenchymal 66 
tissue remodeling with obesity, as well as the development of autologous stem cell 67 
therapies for obese patients. 68 
 69 
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Introduction 77 
Obesity is characterized by chronic low-grade systemic inflammation, which in 78 
addition to insulin resistance 1 is believed to contribute to several musculoskeletal 79 
diseases, such as osteoarthritis (OA) 2 and impaired tissue healing 3. Obesity due to a 80 
high-fat diet is associated with increased lipid deposits found not only in adipose 81 
tissue but also bone marrow 4, liver 5, and heart 6. Increased tissue adiposity is 82 
associated with elevation of several adipose-derived cytokines (adipokines), while 83 
apoptosis and lipolysis of adipocytes promote levels of circulating FFAs in the body. 84 
Importantly, altered cell functions have also been reported in obese individuals. For 85 
example, reduced numbers of endothelial cell have been observed in the bone marrow 86 
of obese patients 7. Wang et al. also found that contribution of bone marrow cells for 87 
tissue homeostasis was affected by diabetes and obesity 8. Results of these studies 88 
suggest altered tissue repair potential in obese patients. Furthermore, adipose tissue-89 
resident macrophages in obese individuals appear to switch from an anti-90 
inflammatory M2 phenotype to an inflammatory M1 phenotype, increasing 91 
inflammatory levels in obesity 9.  92 
The mechanisms by which high fat diet-induced obesity alters cell function are not 93 
fully understood but may involve the chronic exposure to FFAs. FFAs can activate 94 
macrophages through JNK-dependent inflammatory pathways 10. Rat skeletal muscle 95 
cells cultured with FFAs have been reported to show impaired mitochondrial function 96 
11. For osteoblasts and osteoclasts, FFAs have been suggested to modulate bone 97 
formation and resorption 12. Although it is still unclear whether FFAs have an impact 98 
on chondrocyte function, accumulation of lipids in the chondrocytes has been shown 99 
to correlate positively with the degree of OA in patients, implying possible 100 
involvement of FFAs in cartilage degeneration 13.  101 
Mesenchymal stem cells (MSCs) are multipotent cells capable of differentiating into 102 
specific lineages including adipocytes, osteoblasts and chondrocytes14. This potential 103 
allows MSCs to play a significant role in tissue repair and remodeling, particularly 104 
within the marrow itself 15. In addition to their presence in bone marrow, similar but 105 
distinct populations of cells with multilineage potential have been recently identified 106 
in various tissues such as subcutaneous fat (sqASCs)16 and infrapatellar fat pad (IFP 107 
cells) 17. With high-fat diet induced obesity, these tissues are likely to be exposed to 108 
high concentrations of FFAs, and such a change of microenvironment may alter the 109 
characteristics of stem cells resident in these tissues. Indeed, stem cells harvested 110 
from the omental fat (visceral adipose tissue) of obese patients exhibit impaired 111 
multipotency 18. In a simulated obese environment containing the conditioned 112 
medium from FFA-treated adipocytes, MSCs isolated from lean mice demonstrated 113 
decreased adipogenesis but enhanced osteogenesis 19. However, the effects of obesity 114 
or FFAs on the intrinsic cellular properties of adult stem cells, such as in vivo 115 
frequency, self-renewal ability, or multilineage differentiation capacity, is still largely 116 
unknown.  117 
In the present study, we investigated the effects of diet-induced obesity on the 118 
properties and function of several adult stem cell populations. We first isolated MSCs, 119 
sqASCs, and IFP cells from lean and high-fat diet induced obese mice and then 120 
compared their in vivo frequency, proliferation capacity, multipotency, and 121 
immunophenotype. To examine one potential mechanism by which a lard-enriched 122 
high-fat diet affects stem cell multipotency, we further differentiated lean stem cells 123 
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in an in vitro environment rich in FFAs. We used a combination of palmitic acid, 124 
stearic acid (both saturated FA), and oleic acid (monounsaturated FA), as recent 125 
studies have shown that lard-enriched high-fat diet promotes levels of these FFAs in 126 
blood and adipose tissues 20, 21. 127 
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Materials and Methods 128 
Animals 129 
Male C57BL/6J mice fed either a high-fat diet (D12492, 60% energy from fat, 130 
Research Diets, Inc.) or a low-fat diet (D12450B, 10% energy from fat, Research 131 
Diets, Inc.) for 14 weeks were obtained from The Jackson Laboratory. Mice were 132 
sacrificed at 20 weeks of age in accordance with an Institutional Animal Care and Use 133 
Committee (IACUC) approved protocol at Duke University. 134 
 135 
Cell isolation and expansion 136 
Bones (femurs and tibias), subcutaneous adipose tissue (inguinal fat pad), and the IFP 137 
were collected from lean and obese mice and digested at 37 °C with 0.2% collagenase 138 
type I (Worthington) for 1-1.5 hours 22. MSCs were purified for Sca-1+ PDGFRα+ 139 
CD45- Ter119- from the bone fragments as previously described 23, 24and sqASCs 140 
were purified for Sca-1+ CD34+ CD31- CD45- Ter119- from the digested inguinal fat 141 
by the method described by Rodeheffer et al. with a slight modification 25. In 142 
preliminary studies, the same marker combination as sqASCs was used to isolate a 143 
similar cell population from the epididymal fat pad (visASCs).  However, due to their 144 
inability to differentiation into the chondrogenic or adipogenic lineages, these cells 145 
were not included in the overall analysis and are reported in the supplemental data.  A 146 
Cytomation MoFlo® sorter (Beckman Coulter) with 100 μm nozzle was used to sort 147 
cells with designated markers (all antibodies from Biolegend). Due to the small size 148 
of the joint fat pad, stem cells were directly derived as the adherent cell fraction of the 149 
IFP after collagenase digestion 17. 150 
Freshly sorted MSCs and sqASCs were plated at 100 cells/cm2 and 3,000 cells/cm2, 151 
respectively. IFP cells were seeded at 1,500 cells/cm2 for the primary passage. All the 152 
cells were cultured in expansion medium consisting of α-Modified Eagle’s Medium 153 
(αMEM, Invitrogen), 20% lot-selected fetal bovine serum (FBS, Sigma), and 1% 154 
penicillin/streptomycin/fungizone (P/S/F, Invitrogen) in hypoxic conditions (37 °C, 155 
2% O2, 5% CO2, remaining gas N2).  In previous studies, we have shown that these 156 
culture conditions allow for rapid expansion of mouse stem cells while maintaining 157 
their multipotency24. After 8 days with media changes every 3 days, cells were 158 
trypsinized using 0.25% trypsin-EDTA (Sigma) and plated at 3,000 cells/cm2. Cells 159 
were passaged every 5-6 days upon 90% confluence. 160 
 161 
Multilineage differentiation 162 
Passage three cells were pooled from 2 sets of isolations (n = 6 mice per isolation) 163 
and differentiated into adipo-, osteo-, and chondrogenic lineages to evaluate their 164 
multipotency. For adipogenesis, 10,000 cells were cultured in wells of 48 well plates 165 
for 2 days in expansion medium. Media was then switched to control medium 166 
consisting of Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 167 
(DMEM/F12, Lonza) with 10% FBS and 1% P/S/F or adipogenic differentiation 168 
medium consisting of control medium supplemented with (all from Sigma) 33 µM 169 
biotin, 17 µM pantothenate, 1 µM bovine insulin, 1 µM dexamethasone, and for the 170 
first three days 250 µM isobutylmethylxanthine and 2 µM rosiglitazone (Avandia™, 171 
GlaxoSmithKline). Cells were cultured either with control or adipogenic medium for 172 
14 days with media changes every 3 days. Lipid droplets were stained by 0.5% Oil 173 
Red O (Sigma), which was released and quantified by absorbance at 535 nm and 174 
normalized to DNA content measured by Quant-iT™ PicoGreen® (Invitrogen). For 175 
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osteogenesis, 10,000 cells were plated in wells of 48 well plates for 2 days in 176 
expansion medium. Media was then switched to control medium consisting of 177 
DMEM (4.5 g/L glucose, Invitrogen) with 10% FBS and 1% P/S/F or osteogenic 178 
differentiation medium consisting of control medium plus 10 mM β-glycerophosphate 179 
(Sigma), 250 µM ascorbate (Sigma), 2.5 µM retinoic acid (Sigma), and 50 ng/ml 180 
human bone morphogenetic protein-2 (BMP-2, R&D systems) for 21 days with media 181 
changes every 3 days. Mineral deposits were stained by 2% Alizarin Red S (Electron 182 
Microscopy Sciences). The stain was then released by heated acid extraction 26 and 183 
normalized to DNA. For chondrogenesis, 250,000 cells were centrifuged in 15 ml 184 
polypropylene tubes at 300 g for 5 minutes to form pellets. After 2 days, media were 185 
switched to control medium consisting of DMEM (4.5 g/L glucose, Invitrogen), 1% 186 
insulin-transferrin-selenous acid (ITS+, BD), 50 µg/ml ascorbate (Sigma), 40 µg/ml 187 
proline (Sigma), and 1% P/S (Sigma) or chondrogenic differentiation medium 188 
consisting of control medium supplemented with 10 ng/ml human transforming 189 
growth factor-β3 (TGF-β3, R&D systems) and 500 ng/ml mouse bone morphogenetic 190 
protein-6 (BMP-6, R&D systems). For MSCs and IFP cells, serum free control and 191 
chondrogenic medium were used but for sqASCs both media were supplemented with 192 
10% FBS. After 28 days, pellets were analyzed for their glycosaminoglycan (GAG) 193 
and DNA content by 1,9-dimethylmethylene blue (DMB) and PicoGreen assay, 194 
respectively. Some pellets were also processed for histochemical staining for sulfated 195 
GAGs by 1% Alcian Blue (pH = 1, Acros) and immunohistochemical labeling for 196 
collagen type II (Hybridoma Bank). For FFA treated groups, cells were performed as 197 
the same differentiation methods as described above but with the supplement of FFA 198 
mixture or vehicle control as appropriate in their differentiation medium. 199 
 200 
FFA preparation and treatment 201 
To simulate an obese environment rich in saturated fatty acid (SFA) and 202 
monounsaturated fatty acid (MUFA), a FFA mixture (SA/MUFA) containing 203 
palmitic, stearic and oleic acids (NuChek Prep) was used. 3.3 mM stock FFA mixture 204 
was prepared by a method described by Nguyen et al. 10. Briefly, FFA was dissolved 205 
in ethanol and mixed with DMEM (4.5 g/L glucose, Invitrogen) supplemented with 206 
fatty acid-free bovine serum albumin (BSA, Sigma). A ratio of 5:1 FFA:BSA was 207 
used to mimic elevated FFA levels. The FFA-BSA solution was then conjugated at 208 
37°C for 1.5 hr until homogeneous. A vehicle control (Control) that contained BSA 209 
with the same volume of ethanol but no FFA was also prepared. The FFA mixture 210 
was aliquoted and stored at -20 °C until use. In preliminary studies, we examined 211 
effects of several different concentrations (150 µM, 250 µM and 500 µM) of FFA to 212 
test the toxicity of FFA on stem cells. We did not observe any cell death under these 213 
conditions. These cells also maintained their spindle-shaped cell morphology and 214 
were able to reach confluence at a similar rate, independent of FFA concentration 215 
(Supplemental Figure 1). The final concentration of individual FFA used in the 216 
differentiation culture medium was 500 μM. 217 
 218 
Immunophenotype analysis 219 
Passage three cells were divided into aliquots of 100,000 cells, treated with Fc block 220 
(CD16/32) for 10 minutes at 4 °C to reduce unspecific binding, then incubated for 30 221 
minutes at 4 °C with antibodies against following cell surface markers or appropriate 222 
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isotype controls (all from Biolegend):  CD45, CD31, Ter119, CD44, CD11b, platelet-223 
derived growth factor receptor α (PDGFRα), CD34, CD105, stem cell antigen-1 (Sca-224 
1).  A C6 benchtop flow cytometer (Accuri Cytometers) was used for analysis and 225 
percentages obtained by subtracting the value of isotype controls.   226 
 227 
Statistical analysis 228 
Statistical analysis was carried out using a 2-tailed Student’s t-test for comparison of 229 
two groups (α =  0.05). Values are expressed as mean ± SEM. 230 
231 
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Results 232 
Obesity alters stem cell percentage in bone marrow and adipose tissues 233 
Obese mice weighed significantly more than lean mice (40.25 ± 1.17g obese vs. 31.14 234 
± 0.35g lean, p < 0.001). Inguinal fat pads from obese mice were a larger percentage 235 
of total body weight as compared to lean mice (2.43% ± 0.17% obese vs. 0.66% ± 236 
0.03% lean, p < 0.05). Results were averaged from ≥ 15 mice per group with mean ± 237 
SEM displayed. 238 
A highly purified population of MSCs was isolated based on a specific combination 239 
of cell surface markers 23. MSCs were identified as cells that are double-negative for 240 
CD45 and Ter119 (hematopoietic cell markers) and double-positive for Sca-1 and 241 
PDGFRα (stem cell markers) (Figure 1A). Obesity showed a trend toward increased 242 
in vivo frequency of MSCs in obese mice (p = 0.07; Figure 1B). There was no 243 
significant difference in the percentage of CD45- Ter119- population in bone marrow 244 
cells between lean and obese mice (Figure 1C). Interestingly, among this double-245 
negative cell population, obese mice had a significantly higher percentage of Sca-1+ 246 
PDGFRα+ cells. Results were averaged from 5 independent isolations with mean ± 247 
SEM displayed (n ≥ 4 mice per isolation). 248 
To harvest a pure stem cell population from the inguinal fat, a similar sorting strategy 249 
was used but a slightly different combination of cell markers. CD31 has been used to 250 
distinguish endothelial progenitor cells from stem cells 27, while CD34 has been 251 
reported to be expressed on freshly isolated adipose-derived stem cells 28. Therefore, 252 
we defined sqASCs as cells triple-negative for CD31, CD45 and Ter119 but double-253 
positive for Sca-1 and CD34 (Figure 1D). In inguinal fat, obese mice showed a 254 
moderated increase in sqASCs although not significant (Figure 1E). Obesity also had 255 
a trend toward an increased percentage of CD45- CD31- Ter119- cells in the inguinal 256 
fat compared to lean mice (p = 0.09; Figure 1F) but among this triple-negative cell 257 
population, no significant difference was observed in CD34 and Sca-1 double-positive 258 
cells between lean and obese mice. Results were averaged from 3 independent 259 
isolations with mean ± SEM displayed (n ≥ 4 mice per isolation). The cell sorting 260 
yield of MSCs and sqASCs per mouse is summarized in Supplemental Table 1. 261 
MSCs, sqASCs and IFP cells exhibit similar rates of proliferation in vitro  262 
The overall morphology of stem cells was similar between lean and obese mice. All 263 
stem cells exhibited fibroblastic-like morphologies, although sqASCs displayed larger 264 
cell protrusions than MSCs and IFP cells (Figure 2A-F). Cells were cultured through 265 
five passages to investigate their in vitro proliferation (n = 3 independent 266 
experiments). All the cell types proliferated robustly under hypoxic conditions. Lean 267 
MSCs exhibited greater expansion, but it was not significantly different from obese 268 
MSCs (Figure 2G). Both obese sqASCs and IFP cells showed a trend toward 269 
increased proliferation as compared to their corresponding lean cell types (Figure 2H-270 
I).  271 
 272 
MSCs, sqASCs and IFP cells exhibit distinct levels of surface antigens 273 
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Immunophenotype analysis was performed at passage three for each cell type (Table 274 
1). All the stem cells were negative for hematopoietic cell markers (CD11b, CD45 275 
and Ter119; all < 1%) and endothelial progenitor cell marker (CD31; all < 1%) but 276 
positive for Sca-1 (all ≥ 99%). Most cell types were negative for CD34, although IFP 277 
cells showed some CD34 expression. Both MSCs and IFP cells showed high 278 
percentage of cells expressing CD44 and PDGFRα, while sqASCs had fewer cells 279 
expressing these two markers. Obese MSCs showed a trend towards a lower 280 
percentage of cells expressing CD105 but a significantly higher percentage expressing 281 
PDGFRα as compared to lean MSCs (for CD105, p = 0.06; for PDGFRα, p < 0.05). 282 
 283 
Obesity alters the multipotency of adult stem cells in a manner that depends on 284 
the tissue source of the cells 285 
Passage three cells were differentiated into adipo-, osteo- and chondrogenic lineages 286 
(each cell type was pooled from two independent isolations, n = 6 mice per isolation). 287 
For MSCs, obese cells showed significantly reduced adipogenic (Figure 3A-B) and 288 
osteogenic potential (Figure 3C-D) compared to lean MSCs (for adipogenesis, Figure 289 
3E,; for osteogenesis, Figure 3F). When MSCs were differentiated into chondrocytes, 290 
obese MSCs showed a trend toward reduced GAG/DNA ratio, less Alcian Blue and 291 
collagen type II staining intensity compared to lean MSCs (p = 0.07; Figure 4A-E).  292 
When the GAG/DNA ratio was normalized to the GAG/DNA ratio of pellets under 293 
control conditions, this trend was significant (data not shown). 294 
For sqASCs, obese cells showed significantly enhanced adipogenic (Figure 3G-H)  295 
and osteogenic differentiation (Figure 3I-J)  compared to lean sqASCs (for 296 
adipogenesis, Figure 3K; for osteogenesis, Figure 3L). However, lean sqASCs 297 
exhibited greater chondrogenic potential than obese sqASCs (Figure 4F-J).  298 
Similar to sqASCs, obese IFP cells demonstrated significantly increased adipogenesis 299 
(Figure 3M-N) and osteogenesis (Figure 3O-P) compared to lean IFP cells (for 300 
adipogenesis, Figure 3Q; for osteogenesis, Figure 3R). When differentiated into the 301 
chondrogenic lineage, lean IFP cells showed significantly higher GAG/DNA ratio 302 
than obese IFP cells (Figure 4K-O). 303 
While lean IFP cells had significantly higher GAG content per pellet compared to 304 
obese IFP cells, other lean cell types exhibited a trend toward higher GAG content per 305 
pellet compared to corresponding obese cell types (Supplemental Figure 2A-C). 306 
visASCs from the epididymal fat pad showed poor in vitro differentiation capacity for 307 
adipogenic and chondrogenic lineages, and thus the effects of obesity were not 308 
examined in this cell type (Supplemental Figure 3). 309 
A table summarizing the multilineage differentiation capacity of lean and obese stem 310 
cells isolated from different tissues is provided in Supplemental Table 2(A). 311 
 312 
FFA treatment alters the multipotency of lean adult stem cells 313 
To examine the potential influence of increased FFAs, high concentrations of palmitic 314 
and stearic acid as well as oleic acid (SA/MUFA mixture) were supplemented into the 315 
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differentiation media of lean stem cells. When treated with SA/MUFA, lean MSCs 316 
demonstrated significantly enhanced adipogenesis and osteogenesis compared to 317 
vehicle control (for adipogenesis, Figure 5A; for osteogenesis, Figure 5B). However, 318 
there was no significant difference in chondrogenesis between SA/MUFA treated and 319 
vehicle control (Figure 5C).  320 
When treated with SA/MUFA, lean sqASCs demonstrated significantly enhanced 321 
adipogenesis compared to vehicle control (Figure 5D). However, SA/MUFA did not 322 
alter the osteogenesis of lean sqASCs (Figure 5E). Supplementation with SA/MUFA 323 
significantly decreased the chondrogenic capacity (Figure 5F). 324 
Similar to lean sqASCs, lean IFP cells exhibited enhanced adipogenesis but 325 
maintained osteogenic capacity when treated with SA/MUFA (for adipogenesis, 326 
Figure 5G; for osteogenesis, Figure 5H). SA/MUFA treatment also decreased 327 
chondrogenesis of lean IFP cells (Figure 5I). 328 
A table summarizing the multilineage differentiation capacity of FFA-treated lean 329 
stem cells and vehicle control is provided in Supplemental Table 2(B). 330 
 331 
332 
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Discussion 333 
The findings of this study show that high-fat diet induced obesity significantly alters a 334 
number of cellular properties of adult stem cells derived from bone marrow, 335 
subcutaneous fat, and the infrapatellar fat pad. Obesity appeared to increase the in 336 
vivo frequency of stem cells and alter their multilineage potential in a manner that was 337 
dependent on the cell source. Some of these effects were reproduced by culture with 338 
FFAs, suggesting that the increase systemic levels of FFAs associated with a high-fat 339 
diet may be responsible in part for the observed effects.   340 
Our finding of an increased sqASC population is consistent with a previous study 341 
showing that the percentage of proliferating CD34+/CD31- adipose-tissue progenitors 342 
was increased in class I obese patients (BMI 30-34.9 kg/m2) 29. Increased proliferation 343 
of CD34+/Sca-1+ adipose tissue progenitors was also observed in subcutaneous fat 344 
using an in vivo bromodeoxyuridine labeling method after mice were exposed to a 345 
high-fat diet 30. Our obese sqASCs also showed a trend toward increased in vitro 346 
proliferation capacity compared to lean sqASCs. This result is supported by a 347 
previous study showing adipose progenitor cells obtained from subcutaneous fat pad 348 
of high BMI individuals exhibited higher proliferation than those from low BMI 349 
individuals 31. The expanded stem cell populations may reflect increased adipogenic 350 
differentiation in the marrow and possibly a commitment into an endothelial lineage 351 
for adapting hypoxic conditions in vivo 32.  There is also evidence that stem cells are 352 
associated with vasculature 33, and increased tissue adiposity may increase vascularity 353 
and thus the stem cell pool. 354 
Obesity had a consistent inhibitory effect on multilineage potential of MSCs. Our 355 
results are in agreement with a recent study showing that stem cells isolated from lean 356 
individuals demonstrated better multipotency in mesodermal lineages than those from 357 
obese individuals 18. MSCs are the common precursor cells for both adipocytes and 358 
osteoblasts in bone marrow 34. The relationships between marrow fat and bone density 359 
in response to obesity is not fully understood and is an area of intensive 360 
investigations. Increased body mass seems to encourage bone formation, but 361 
inflammation due to excessive fat tissues may be detrimental to osteogenesis 35, 36. 362 
Our findings provide evidence that obesity results in reduced in vitro adipogenic and 363 
osteogenic capacity of MSCs.  364 
Obese sqASCs and IFP cells both exhibited significantly enhanced adipogenesis and a 365 
trend toward higher proliferation as compared to their corresponding lean cell types. 366 
These findings imply that subcutaneous fat and infrapatellar fat pad may have 367 
increased fat-storing capacities during weight gain. Several studies have shown that 368 
subcutaneous adipose tissues expand fat mass by hyperplasia (increased adipocyte 369 
numbers) instead of hypertrophy (increased adipocyte size) which particularly occurs 370 
in visceral fat depot such as epididymal fat pad 30. Increased adipocytes can arise from 371 
the proliferation and adipogenic differentiation of sqASCs, as adipocytes are 372 
terminally differentiated cells and incapable of proliferation 37. In our preliminary 373 
studies, we also observed that adult stem cells isolated from epididymal fat pad had 374 
lower adipogenesis compared to sqASCs (Supplemental Figure 3).  Compared to 375 
large adipocytes, new smaller adipocytes have better capacity in up-taking excess 376 
FFAs and therefore protect adipocytes from apoptosis 38, which may inhibit 377 
infiltration of inflammatory macrophages into adipose tissues 39. To investigate 378 
whether macrophages infiltrate into obese joint fat pads, inguinal fat, and epididymal 379 
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fat, these tissues harvested from lean and obese mice were stained with an antibody 380 
against epidermal growth factor seven transmembrane protein (F4/80) expressed on 381 
macrophages. Interestingly, in contrast to obese visceral fat, we did not observe 382 
massively infiltrated macrophages in the obese IFP and inguinal fat pad 383 
(Supplemental Figure 4).  384 
In this study, we also observed that both sqASCs and IFP cells from obese mice 385 
exhibited significantly higher in vitro osteogenesis. Recent studies have suggested 386 
that osteogenesis is closely linked to Wnt/β-catenin signaling pathways 40 and 387 
microRNA expressions such as miR-26a, -133 and -135 41, 42. Whether obese sqASCs 388 
and IFP cells have dysregulated Wnt signaling or altered microRNA levels requires 389 
further investigation. 390 
Several approaches for cartilage repair and regeneration rely on chondrogenesis of 391 
stem cells. For example, microfracture is a procedure to stimulate MSC migration 392 
directly from bone marrow into focal cartilage defects 43. Scaffolds seeded with 393 
culture-expanded autologous adult stem cells for cartilage repair are also currently 394 
undergoing intensive investigation44. However, the potential impact of obesity on the 395 
intrinsic chondrogenic ability of these cells is not well understood. Our data show that 396 
obese MSCs, sqASCs and IFP cells exhibit decreased production of GAGs and 397 
collagen type II, implying that obesity might interfere with cartilage repair during 398 
autologous stem cell therapy.  399 
While our results indicate that obesity significantly affected the multipotency of stem 400 
cells, we did not observe changes in antigen expression levels in sqASCs and IFP 401 
cells after exposed to a high-fat diet. Nevertheless, we cannot exclude possible 402 
alterations in other antigens such as Toll-like receptors (TLRs), which have been 403 
shown to modulate stem cell functions 45.  Interestingly, obese MSCs did show a trend 404 
toward decreased percentage of the cells expressing CD105. CD105, also known as 405 
endoglin, is an accessory protein in mediating signaling of TGF-β superfamily 46, and 406 
it is well known that TGF-β up-regulates the key transcription factor Sox9, critical for 407 
the commitment of MSCs to the chondrogenic lineage 47. It has been shown that 408 
downstream SMAD signaling of CD105 is required for onset of chondrogenesis of 409 
MSCs 48. Furthermore, we also found that obese MSCs had a significantly increased 410 
percentage of cells expressing PDGFRα. Previous studies have suggested that PDGF-411 
AA promotes early stages of cartilage development of chicken embryo but may 412 
inhibit chondrogenesis at later stages 49. Recent studies have shown that hypoxia-413 
conditioned human embryonic stem cells chondrogenesis was associated with a high 414 
CD105 but low PDGRFα expression profile 50. Our results in accordance with above 415 
studies indicate that the decreased chondrogenic capacity of obese MSCs could be 416 
potentially due to down-regulated expression of CD105 but up-regulated expression 417 
of PDGFRα.  418 
Our findings also demonstrated that SA/MUFA strongly affected the multilineage 419 
potential of lean stem cells. MSCs treated with SA/MUFA up-regulated both 420 
adipogenic and osteogenic potentials but showed no marked alteration in 421 
chondrogenic ability. Our result of enhanced osteogenesis by SA/MUFA is supported 422 
by previous findings that oleic acid significantly promoted osteogenesis of mouse 423 
mesenchymal cells in the presence of BMP-2 51. Saturated FFAs, acting as 424 
lipopolysaccharide (LPS), can activate TLR4 via triggering MyD88-dependent 425 
pathways 52, shifting cytokine secretion profile in MSCs 53. Furthermore, human 426 
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MSCs with prolonged LPS treatment have been shown to exhibit enhanced osteogenic 427 
capacity 54. It is therefore plausible that palmitic and stearic acids in the FFA mixture 428 
we used both contributed to promote osteogenic differentiation of lean MSCs. 429 
However, murine MSCs showed enhanced osteogenesis but decreased adipogenesis 430 
when cultured in a simulated obese environment containing the conditioned medium 431 
of palmitic and oleic acid-treated adipocytes 19. This discrepancy may be a result of 432 
the different culture methods. The conditioned medium secreted by FFA-treated 433 
adipocytes might contain other cytokines that modulate stem cell functions.  434 
We also observed that lean sqASCs and IFP cells had a similar response to FFA 435 
treatment in differentiation into three mesodermal lineages, although these cells 436 
exhibit distinct phenotypes. To date, few studies have investigated how SFA and 437 
MUFA modulate functions of adipose tissue stem cells, despite the fact that these two 438 
types of FFAs constitute an important part of our diets 55. ManicKam et al. reported 439 
that no significant alteration in lipid accumulation was observed when 3T3-L1 cells 440 
were treated with either stearic or oleic acid56. However, pre-adipocyte cell lines 441 
might have different responses to obesity compared to multipotent stem cells that are 442 
higher in the stem cell hierarchy. Future investigations are necessary to elucidate the 443 
molecular mechanism(s) by which SFA and MUFA modulate multipotency of stem 444 
cells. 445 
Another significant finding of this study is that FFA-altered multipotency of lean stem 446 
cells did not completely recapitulate the multipotency of stem cells directly harvested 447 
from obese mice. This result suggests that the exposure to FFAs alone cannot explain 448 
the alterations of stem cell functions in the obese environment, and it also implies that 449 
other obesity-associated cytokines might act synergically with FFAs on stem cells. 450 
Indeed, leptin, an adipokine often up-regulated in obesity, has been shown to 451 
modulate the balance between adipogenesis and osteogenesis of mouse and human 452 
mesenchymal progenitor cells 57. In addition to adipokines, a number of studies have 453 
also reported that inflammatory cytokines such as TNF-α can inhibit osteogenesis of 454 
stem cells58. Moreover, that IL-17A produced by CD4+ Th17 cells, a possible 455 
infiltrating immune cells during weight gain, significantly suppresses adipogenic 456 
differentiation of human MSCs via the COX-2/prostaglandin E2 pathway59.  457 
One potential limitation of the current study is that multipotency of the stem cells was 458 
evaluated only by using histological and biochemical assays. Although previous 459 
studies have shown that these assays are reflected by similar changes in gene 460 
expression 60, detailed gene expression analysis may provide insight into whether lean 461 
and obese stem cells have a temporal difference in response to differentiation-462 
inducing signals. To examine the specific mechanism(s) underlying the alteration of 463 
stem cell functions caused by obesity or FFA treatment, future studies may wish to 464 
investigate the genetic and/or epigenetic profile of these cells following 465 
differentiation into various lineages.466 
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Conclusions 467 
Our results indicate that obesity significantly alters the characteristics of stem cells 468 
resident in various tissues. This study is significant for the development of autologous 469 
stem cell therapy for obese patients as obesity is highly prevalent in the US and 470 
continuously increasing in other countries. An improved understanding of the effects 471 
of obesity on the adult stem cell pool may help in optimizing the response of obese 472 
stem cells, which may be necessary to enhance their therapeutic capacity. Our finding 473 
of an increased stem cell pool with altered properties in various obese tissues extends 474 
our understanding of the mechanisms underlying the remodeling of musculoskeletal 475 
tissues in obesity. 476 
477 
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Figure 1. Representative stem cell sorting result of (A-C) bone marrow and (D-F) 734 
inguinal fat from lean mice. In the bone marrow of lean mice, approximately 1% of 735 
stromal cells were Ter119/CD45 double-negative (green dots). Only 5% of these cells 736 
were Sca-1/PDGFRα double-positive (red dots) and the cells that were Sca-1+ 737 
PDGFRα+ Ter119- CD45- were identified as MSCs. In inguinal fat of lean mice, 738 
around 24% of adipose-tissue stromal cells were CD31/Ter119/CD45 triple-negative 739 
(green dots). Among this population, 63% were Sca-1/CD34 double-positive (red 740 
dots) and sqASCs were designated as the cells that were Sca-1+ CD34+ CD31- 741 
Ter119- CD45- . Obese mice showed a trend toward increased in vivo frequency of 742 
(B) MSCs (n = 5 isolations ) and (E) sqASCs (n = 3  isolations ). n ≥ 4 mice per 743 
isolation. In the stem cell population, obesity significantly increased (C) the 744 
percentage of Sca-1+ PDGFRα+ cells (red bar) among Ter119- CD45-  cell 745 
population (green bar) in the bone marrow (# p < 0.05 vs. corresponding lean cell 746 
population ). (F) Obese mice showed a trend toward increased CD45- CD31- Ter119- 747 
cells (green bar) in the inguinal fat.  748 
749 
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Figure 2. Morphology of (A, C, E) lean and (B, D, F) obese stem cells at passage 3. 750 
The cumulative fold increase during expansion under hypoxic conditions through 751 
passage 5 of (G) MSCs (H) sqASCs and (I) IFP cells harvested from lean and obese 752 
mice. Obese sqASCs and IFP cells showed a trend toward increased proliferation, 753 
while obese MSCs had a trend toward decreased cell growth. Results averaged from 3 754 
independent isolations with mean ± SEM displayed (n ≥ 3 mice per isolation). Scale 755 
bar is 100 µm.  756 
757 
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Figure 3. Adipogenesis and osteogenesis of stem cells harvested from lean and obese 758 
mice. Lipid droplets accumulation in (A, G, M) lean and (B, H, N) obese stem cells 759 
after 14 days culture in adipogenic medium. Cells were stained with 0.5% Oil Red O. 760 
Stain was then released and normalized to DNA content to quantify adipogenic 761 
potential of (E) MSCs, (K) sqASCs and (Q) IFP cells. For osteogenesis, calcium 762 
mineral deposits stained with 2% Alizarin Red S in (C, I, O) lean and (D, J, P) obese 763 
stem cells after 21 days culture in osteogenic medium. Stain was then extracted and 764 
normalized to DNA content to determine osteogenic capacity of (F) MSCs, (L) 765 
sqASCs and (R) IFP cells. Results from ≥ 5 samples per group of the cells pooled 766 
from two independent isolations (n = 6 mice per isolation) with mean ± SEM 767 
displayed. # p < 0.05 vs. corresponding lean cell type by t-test. Scale bar is 100 µm 768 
for adipo- and 5 mm for osteogenesis, respectively.  769 
770 
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Figure 4. Sulfated GAGs and proteoglycans of chondrogenic pellets from (A, F, K) 771 
lean stem cells and (B, G, L) obese stem cells after 28 days pellet culture in 772 
chondrogenic medium was detected by 1% Alcian Blue staining (pH = 1). Collagen II 773 
immunohistochemical staining was also performed for the pellets from (C, H, M) 774 
lean stem cells and (D, I, N) obese stem cells. Quantification of GAG content was 775 
performed by DMB assay and the value was then further normalized to DNA to 776 
determine chondrogenic potential of (E) MSCs, (J) sqASCs and (O) IFP cells. Obese 777 
MSCs exhibited a trend toward decreased chondrogenesis (p = 0.07 vs. lean MSCs), 778 
while obese sqASCs and IFP cells showed significantly decreased chondrogenic 779 
capacity. Results from ≥ 4 pellets per group of the cells pooled from two independent 780 
isolations (n = 6 mice per isolation) with mean ± SEM displayed. # p < 0.05 vs. 781 
corresponding lean cell type by t-test. Scale bar is 500 μm.     782 
783 
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Figure 5. Multi-lineage differentiation of lean stem cells with supplement of 784 
SA/MUFA. (A, D, G) all the stem cells treated with SA/MUFA demonstrated 785 
increased adipogenesis. SA/MUFA also significantly enhanced  (B) osteogenesis of 786 
MSCs but did not significantly affect (E, H) osteogenic potential of sqASCs and IFP 787 
cells. However, MSCs did not alter (C) chondrogenic potential in response to 788 
SA/MUFA but the treatment of SA/MUFA significantly decreased (F, I) 789 
chondrogenic capacity of sqASCs and IFP cells. Results from 5 samples (for 790 
adipogenesis and osteogenesis) or ≥ 4 pellets (for chondrogenesis) per group of the 791 
cells pooled from two independent isolations (n = 6 mice per isolation) with mean ± 792 
SEM displayed. # p < 0.05 vs. vehicle control by t-test.  793 
794 
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Table 1. Immunophenotype analysis for passage 3 stem cells from lean and obese 795 
mice. In response to obesity, sqASCs and IFP cells did not significantly alter surface 796 
marker expression. Interestingly, however, obesity significantly increased percentage 797 
of the MSCs expressing PDGFRα but a trend toward to decrease CD105 level. 798 
Results from 3 independent experiments for PDGFRα and CD105 in lean and obese 799 
MSCs with mean ± SEM displayed (n ≥ 3 mice per experiment. Values with different 800 
superscript letters are significantly different; p < 0.05) . For other cell types, results 801 
averaged from of 2 independent experiments (n ≥ 3 mice per experiment).    802 
 803 






